ICU Medical, Inc.
NASDAQ:ICUIMedical - Instruments & Supplies
+$0.89 today
- Market cap
- $4.46B
- Beta
- 0.78
- P/E (TTM)
- 74.2
- EPS (TTM)
- $1.87
Volume 0.21M
Average 0.29M
ICUI Net Income
Bottom-line profit, the starting point for calculating cash from operations.
ICU Medical, Inc.NASDAQ: ICUI
Net Income · Q2 FY2026 · quarter ended Jun 2026
Net income dips below year-ago levels
Q2 FY2026 net income of $19.09M fell 46.0% year over year, behind the +181.4% change in trailing-twelve-month net income. Sequentially, it fell 36.7% from the prior quarter.
Context
- Net income amounted to 0.0% of revenue in FY2025, down 4.9 pp from a year earlier.
- Net income increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether net income reaches the consensus estimate from 7 analysts of $222.68M (+30321.0%) for the fiscal year ending Dec 2026, a step up from the +100.6% reported in FY2025.
Sources:Cash Flow Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterJun 2026
- $19.09M-36.7% QoQ
- Last fiscal yearDec 2025
- $732K+100.6% YoY
- LTMJun 2026
- $30.09M+181.4% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | -46.0% | +1682.4% | +1728.4 pp |
| 1 year | +100.6% | +30321.0% | +30220.4 pp |
| 3-year CAGR | — | +615.4% | — |
| 5-year CAGR | +227.6% | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Net Income history
USD · from the cash flow
- Latest · FY2025
- 732K USD
- Year-over-year change
- +100.6%
- 4-year CAGR
- -71.0%
| Period | Period end | Net Income | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 732K | +100.6% |
| FY2024 | 2024-12-31 | (117.69M) | -296.9% |
| FY2023 | 2023-12-31 | (29.66M) | +60.1% |
| FY2022 | 2022-12-31 | (74.29M) | -172.0% |
| FY2021 | 2021-12-31 | 103.14M | — |
Net Income vs competitors
How ICUI compares with its peers on the latest reported figures
- ICUI's LTM Jun 2026 net income of $30.09M is the 4th largest of the 5 companies compared; the peer median is $161.59M.
- Its year-over-year change of +181.4% is the 2nd highest of 5, against a peer median of -42.2%.
- Net income amounts to 1.4% of revenue for ICUI, versus a peer median of 7.3%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $1.22B | -27.5% | -9.2% | 6.0% | |
| LTM Jun 2026 | $975M | +304.6% | -32.5% | 8.5% | |
| LTM Jun 2026 | $320.9M | -267.2% | -45.6% | 12.3% | |
| LTM Jun 2026 | $30.09M | +181.4% | — | 1.4% | |
| LTM Mar 2026 | $2.28M | -57.0% | -32.7% | 5.3% | |
| Peer median (excluding ICUI) | $161.59M | -42.2% | -32.6% | 7.3% | |
Competitors are the stored peer set for ICUI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 103.14M | (74.29M) | (29.66M) | (117.69M) | 732K |
| Depreciation & Amortization | 89.7M | 235.15M | 228.77M | 219.51M | 200.74M |
| Deferred Income Tax | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 27.34M | 36.03M | 40.56M | 46.88M | 55.76M |
| Change in Working Capital | 15.04M | (303.73M) | (135.6M) | (2.57M) | (90.04M) |
| Accounts Receivables | 13.76M | (19.15M) | 48.64M | (46.84M) | 8.88M |
| Inventory | 20.82M | (201.1M) | (6.08M) | 16.83M | (26.25M) |
| Accounts Payables | 2.35M | 37.47M | (68.3M) | 12.53M | 7M |
| Other Working Capital | (21.88M) | (120.96M) | (109.86M) | 14.92M | (79.67M) |
| Other Non-Cash Items | 32.33M | 44.71M | 62.12M | 57.9M | 12.66M |
| Operating Cash Flow | 267.54M | (62.13M) | 166.2M | 204.03M | 179.85M |
| Capital Expenditures | (81.17M) | (99.33M) | (93.67M) | (79.37M) | (88.04M) |
| Acquisitions (Net) | (14.45M) | (1.84B) | 0 | 0 | 0 |
| Purchases of Investments | (13.28M) | (3.4M) | 0 | 0 | 0 |
| Sales of Investments | 18M | 36.43M | 4.22M | 500K | 0 |
| Other Investing Activities | (12.41M) | (8.03M) | (8.28M) | (10.09M) | 210.27M |
| Investing Cash Flow | (90.69M) | (1.91B) | (87.95M) | (88.96M) | 122.23M |
| Debt Repayment | (607K) | 1.64B | (30.65M) | (52.15M) | (308.87M) |
| Common Stock Issued | 9.37M | 8.79M | 4.02M | 10.94M | 6.11M |
| Common Stock Repurchased | 0 | 0 | (9.35M) | (11.99M) | (8.77M) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (25.64M) | (13.06M) | 0 | (2.6M) | 0 |
| Financing Cash Flow | (16.87M) | 1.64B | (35.98M) | (55.8M) | (311.53M) |
| Effect of Forex Changes | (3.25M) | (9.48M) | 3.16M | (4.93M) | 8.85M |
| Net Change in Cash | 156.73M | (344.04M) | 45.44M | 54.34M | (603K) |
| Free Cash Flow | 186.37M | (161.46M) | 72.53M | 124.66M | 91.8M |
ICU Medical, Inc.
NASDAQ:ICUI
Intrinsic Alpha fair value
Locked
Current Price
$178.48
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.